Logo Logo
  • Home
  • Publications
  • Meet Our Team
  • Contact

More Info

  • Email [email protected]
  • Phone Office: (434) 924-8195 Computational lab: (434) 982-6267 Wet lab: (434) 924-8640
  • Location 415 Lane Road, Room 2041 Charlottesville, VA 22903

Related Links

  • PubMed
  • Undergraduate Opportunities
  • Graduate Opportunities
  • UVA Engineering

Connect With Us

Novel Plasmodium falciparum metabolic network reconstruction identifies shifts associated with clinical antimalarial resistance

  • Home
  • Blog Details
July 21 2017
  • Published Works

BMC Genomics. 2017 Jul 19;18(1):543. doi: 10.1186/s12864-017-3905-1.

ABSTRACT

BACKGROUND: Malaria remains a major public health burden and resistance has emerged to every antimalarial on the market, including the frontline drug, artemisinin. Our limited understanding of Plasmodium biology hinders the elucidation of resistance mechanisms. In this regard, systems biology approaches can facilitate the integration of existing experimental knowledge and further understanding of these mechanisms.

RESULTS: Here, we developed a novel genome-scale metabolic network reconstruction, iPfal17, of the asexual blood-stage P. falciparum parasite to expand our understanding of metabolic changes that support resistance. We identified 11 metabolic tasks to evaluate iPfal17 performance. Flux balance analysis and simulation of gene knockouts and enzyme inhibition predict candidate drug targets unique to resistant parasites. Moreover, integration of clinical parasite transcriptomes into the iPfal17 reconstruction reveals patterns associated with antimalarial resistance. These results predict that artemisinin sensitive and resistant parasites differentially utilize scavenging and biosynthetic pathways for multiple essential metabolites, including folate and polyamines. Our findings are consistent with experimental literature, while generating novel hypotheses about artemisinin resistance and parasite biology. We detect evidence that resistant parasites maintain greater metabolic flexibility, perhaps representing an incomplete transition to the metabolic state most appropriate for nutrient-rich blood.

CONCLUSION: Using this systems biology approach, we identify metabolic shifts that arise with or in support of the resistant phenotype. This perspective allows us to more productively analyze and interpret clinical expression data for the identification of candidate drug targets for the treatment of resistant parasites.

PMID:28724354 | PMC:PMC5518114 | DOI:10.1186/s12864-017-3905-1

Previous Post Next Post

Recent Posts

  • Fecal sphingolipids predict parenteral nutrition associated cholestasis in the neonatal intensive care unit
  • Comparative analyses of parasites with a comprehensive database of genome-scale metabolic models
  • Comparative analyses of parasites with a comprehensive database of geno-scale metabolic models
  • Quantifying cumulative phenotypic and genomic evidence for procedural generation of metabolic network reconstructions
  • Computational approaches to understanding Clostridioides difficile metabolism and virulence
Logo

Computational Systems Biology Laboratory; The research group of Dr. Jason Papin in the Department of Biomedical Engineering at the University of Virginia. Dedicated to discovering revolutionary advancements.

Related Links

  • PubMed
  • Undergraduate Opportunities
  • Graduate Opportunities
  • UVA Engineering

Contact Info

The research group of Dr. Jason Papin in the Department of Biomedical Engineering at the University of Virginia

  • Email: [email protected]
  • Phone (434) 924-8195

© Copyright 2021 Papin Lab. Designed by Sabres Media LLC

  • Home
  • Publications
  • Meet Our Team
  • Contact